Abstract
1. Experiments were done to characterize a putative adrenoceptor which functions to inhibit longitudinal muscle tension development in the guinea-pig ileum. Several phenylethylamine based agonists were investigated: BRL 37344, (-)-isoprenaline, (+)-isoprenaline, noradrenaline, adrenaline, and fenoterol. Propranolol and nadolol were tested as antagonists. Agonist-induced inhibition of the contractile response to histamine was measured under equilibrium conditions with alpha-adrenoceptors and muscarinic cholinoceptors inhibited. 2. Inhibitory responses were obtained to (-)-isoprenaline and BRL 37344 that were resistant to beta-adrenoceptor blockage with propranolol (5 microM) and nadolol (10 microM). These resistant responses were antagonized by much higher concentrations of nadolol (30 to 1000 microM) yielding apparent pA2 values for nadolol of 4.31 with (-)-isoprenaline as the agonist, and 4.68 with BRL 37344 as the agonist. Similar apparent pA2 values for nadolol at the putative adrenoceptor were obtained with noradrenaline (4.79), adrenaline (4.68), and fenoterol (4.38). 3. The order and relative potency of agonists at the putative adrenoceptor was: BRL 37344 (20) greater than (-)-isoprenaline (8) greater than noradrenaline (1) greater than adrenaline (0.5) greater than fenoterol (0.35) greater than (+)-isoprenaline (0.27). 4. The resistance to blockade by propranolol (5 microM), the low affinity of nadolol, and the order and relative potency of agonists, suggest the presence of an adrenoceptor with distinct pharmacological characteristics from currently defined alpha- and beta-adrenoceptors.
Full text
PDF











Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Arch J. R., Ainsworth A. T., Cawthorne M. A., Piercy V., Sennitt M. V., Thody V. E., Wilson C., Wilson S. Atypical beta-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature. 1984 May 10;309(5964):163–165. doi: 10.1038/309163a0. [DOI] [PubMed] [Google Scholar]
- Bentley G. A., Starr J. The antinociceptive action of some beta-adrenoceptor agonists in mice. Br J Pharmacol. 1986 Jul;88(3):515–521. doi: 10.1111/j.1476-5381.1986.tb10231.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Berthelsen S., Pettinger W. A. A functional basis for classification of alpha-adrenergic receptors. Life Sci. 1977 Sep 1;21(5):595–606. doi: 10.1016/0024-3205(77)90066-2. [DOI] [PubMed] [Google Scholar]
- Bond R. A., Charlton K. G., Clarke D. E. Evidence for a receptor mediated action of norepinephrine distinct from alpha- and beta-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol. 1986 Nov;334(3):261–266. doi: 10.1007/BF00508780. [DOI] [PubMed] [Google Scholar]
- Bond R. A., Clarke D. E. A response to isoprenaline unrelated to alpha- and beta-adrenoceptor agonism. Br J Pharmacol. 1987 Jul;91(3):683–686. doi: 10.1111/j.1476-5381.1987.tb11262.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Burnstock G. Nervous control of smooth muscle by transmitters, cotransmitters and modulators. Experientia. 1985 Jul 15;41(7):869–874. doi: 10.1007/BF01970003. [DOI] [PubMed] [Google Scholar]
- Croci T., Cecchi R., Tarantino A., Aureggi G., Bianchetti A., Boigegrain R., Manara L. Inhibition of rat colon motility by stimulation of atypical beta-adrenoceptors with new gut-specific agents. Pharmacol Res Commun. 1988 Feb;20(2):147–151. doi: 10.1016/s0031-6989(88)80007-9. [DOI] [PubMed] [Google Scholar]
- Drew G. M., Hilditch A. Prejunctional dopamine receptors modulate twitch responses to parasympathetic nerve stimulation in the rabbit isolated rectococcygeus muscle. Br J Pharmacol. 1984 Dec;83(4):871–881. doi: 10.1111/j.1476-5381.1984.tb16526.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eglen R. M., Whiting R. L. Muscarinic receptor subtypes: a critique of the current classification and a proposal for a working nomenclature. J Auton Pharmacol. 1986 Dec;6(4):323–346. doi: 10.1111/j.1474-8673.1986.tb00661.x. [DOI] [PubMed] [Google Scholar]
- Farmer J. B., Levy G. P. Differentiation of beta-adrenoreceptors by the use of blocking agents. J Pharm Pharmacol. 1970 Feb;22(2):145–146. doi: 10.1111/j.2042-7158.1970.tb08414.x. [DOI] [PubMed] [Google Scholar]
- Feniuk W., Humphrey P. P., Watts A. D. 5-Hydroxytryptamine-induced relaxation of isolated mammalian smooth muscle. Eur J Pharmacol. 1983 Dec 9;96(1-2):71–78. doi: 10.1016/0014-2999(83)90530-7. [DOI] [PubMed] [Google Scholar]
- Grassby P. F., Broadley K. J. Characterization of beta-adrenoceptors mediating relaxation of the guinea-pig ileum. J Pharm Pharmacol. 1984 Sep;36(9):602–607. doi: 10.1111/j.2042-7158.1984.tb04906.x. [DOI] [PubMed] [Google Scholar]
- Grassby P. F., Broadley K. J. Partial agonists at guinea-pig atrial beta-adrenoceptors display relaxation responses in the guinea-pig ileum independent of beta-adrenoceptor stimulation. Gen Pharmacol. 1987;18(1):25–31. doi: 10.1016/0306-3623(87)90164-9. [DOI] [PubMed] [Google Scholar]
- Görich R., Weihrauch T. R., Kilbinger H. The inhibition by dopamine of cholinergic transmission in the isolated guinea-pig ileum. Mediation through alpha-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol. 1982 Mar;318(4):308–312. doi: 10.1007/BF00501170. [DOI] [PubMed] [Google Scholar]
- Harms H. H. Isoproterenol antagonism of cardioselective beta adrenergic receptor blocking agents: a comparative study of human and guinea-pig cardiac and bronchial beta adrenergic receptors. J Pharmacol Exp Ther. 1976 Nov;199(2):329–335. [PubMed] [Google Scholar]
- Harms H. H., Zaagsma J., de Vente J. Differentiation of beta-adrenoceptors in right atrium, diaphragm and adipose tissue of the rat, using stereoisomers of propranolol, alprenolol, nifenalol and practolol. Life Sci. 1977 Jul 1;21(1):123–128. doi: 10.1016/0024-3205(77)90432-5. [DOI] [PubMed] [Google Scholar]
- Hughes I. E., Mackay D. Quantification of the characteristics of antagonists exhibiting both competitive antagonism and functional interaction. Br J Pharmacol. 1985 May;85(1):271–275. doi: 10.1111/j.1476-5381.1985.tb08856.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kalkman H. O., Engel G., Hoyer D. Inhibition of 5-carboxamidotryptamine-induced relaxation of guinea-pig ileum correlates with [125I]LSD binding. Eur J Pharmacol. 1986 Sep 23;129(1-2):139–145. doi: 10.1016/0014-2999(86)90345-6. [DOI] [PubMed] [Google Scholar]
- Kenakin T. P., Beek D. The effects on Schild regressions of antagonist removal from the receptor compartment by a saturable process. Naunyn Schmiedebergs Arch Pharmacol. 1987 Feb;335(2):103–108. doi: 10.1007/BF00177709. [DOI] [PubMed] [Google Scholar]
- Kenakin T. P. The classification of drugs and drug receptors in isolated tissues. Pharmacol Rev. 1984 Sep;36(3):165–222. [PubMed] [Google Scholar]
- Lands A. M., Arnold A., McAuliff J. P., Luduena F. P., Brown T. G., Jr Differentiation of receptor systems activated by sympathomimetic amines. Nature. 1967 May 6;214(5088):597–598. doi: 10.1038/214597a0. [DOI] [PubMed] [Google Scholar]
- Lands A. M., Luduena F. P., Buzzo H. J. Differentiation of receptors responsive to isoproterenol. Life Sci. 1967 Nov 1;6(21):2241–2249. doi: 10.1016/0024-3205(67)90031-8. [DOI] [PubMed] [Google Scholar]
- Langer S. Z. Presynaptic regulation of catecholamine release. Biochem Pharmacol. 1974 Jul 1;23(13):1793–1800. doi: 10.1016/0006-2952(74)90187-7. [DOI] [PubMed] [Google Scholar]
- Lee R. J., Evans D. B., Baky S. H., Laffan R. J. Pharmacology of nadolol (SQ 11725), a beta-adrenergic antagonist lacking direct myocardial depression. Eur J Pharmacol. 1975 Sep-Oct;33(2):371–382. doi: 10.1016/0014-2999(75)90182-x. [DOI] [PubMed] [Google Scholar]
- Maisel A. S., Motulsky H. J., Insel P. A. Life cycles of cardiac alpha 1- and beta-adrenergic receptors. Biochem Pharmacol. 1987 Jan 1;36(1):1–6. doi: 10.1016/0006-2952(87)90375-3. [DOI] [PubMed] [Google Scholar]
- Mian M. A., Malta E., Raper C. An homogeneous population of beta 1-adrenoceptors subserves inhibitory responses in guinea-pig ileal preparations. J Pharm Pharmacol. 1984 Oct;36(10):698–699. doi: 10.1111/j.2042-7158.1984.tb04849.x. [DOI] [PubMed] [Google Scholar]
- Morris J. L., Gibbins I. L., Clevers J. Resistance of adrenergic neurotransmission in the toad heart to adrenoceptor blockade. Naunyn Schmiedebergs Arch Pharmacol. 1981;317(4):331–338. doi: 10.1007/BF00501315. [DOI] [PubMed] [Google Scholar]
- O'Donnell S. R., Wanstall J. C. The importance of choice of agonist in studies designed to predict beta 2 : beta 1 adrenoceptor selectivity of antagonists from pA2 values on guinea-pig trachea and atria. Naunyn Schmiedebergs Arch Pharmacol. 1979 Sep;308(3):183–190. doi: 10.1007/BF00501381. [DOI] [PubMed] [Google Scholar]
- Rang H. P. The kinetics of action of acetylcholine antagonists in smooth muscle. Proc R Soc Lond B Biol Sci. 1966 Apr 19;164(996):488–510. doi: 10.1098/rspb.1966.0045. [DOI] [PubMed] [Google Scholar]
- Stone M., Angus J. A. Developments of computer-based estimation of pA2 values and associated analysis. J Pharmacol Exp Ther. 1978 Dec;207(3):705–718. [PubMed] [Google Scholar]
- Wilson C., Wilson S., Piercy V., Sennitt M. V., Arch J. R. The rat lipolytic beta-adrenoceptor: studies using novel beta-adrenoceptor agonists. Eur J Pharmacol. 1984 May 4;100(3-4):309–319. doi: 10.1016/0014-2999(84)90007-4. [DOI] [PubMed] [Google Scholar]